Biological Safety Testing Market Outlook: Industry Growth Factors, Applications, Regional Analysis, Key Players and Forecasts by 2025

Nov 11, 2019

MarketStudyReport.com Adds New Biological Safety Testing Market 2019- 2025 research report providing information and By Products and Services, By Test, By Application, By End-use, Industry Analysis, Regional Outlook, Application Potential, Competitive Market Share & Forecast spreading across 150 Pages with table and figures in it.

Selbyville, Delaware - November 11, 2019 /MarketersMedia/ —

Canada biological safety testing market was valued at over USD 81.0 million in 2018 and will witness momentous growth till 2025. Growing spending on pharmaceutical and vaccines industry will form the major factor boosting the market growth. Moreover, implementation of technologically advanced products and developing healthcare infrastructure will significantly impact the industry size. Thus, escalating manufacturing facilities and favorable government initiatives for implementation of biological safety testing will aid Canada biological safety testing business growth in upcoming years.

Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/2337490/

Biological Safety Testing Market is expected to exceed USD 4.5 billion by 2025. Increasing implementation of biological safety testing for safe and microbe-free production of biologics and pharmaceutical products will propel market growth.

Biological safety testing services market will foresee 12.4% CAGR in the future years due to growing need of biologics manufacturing companies to reduce cost burden. Various service providers including Charles River, Eurofins Scientific and BioOutsource offer a wide range of test types that can be customized to meet specific requirements as per different biopharmaceutical products. Also, leading service providers are investing in set-up of facilities for business expansion. Thus, with growing pharmaceutical industry size, the adoption of biological safety testing services will significantly spur in the forthcoming years.

Stem cells market is projected to progress at robust pace over the analysis period. Burden of diseases including congenital disorders, arthritis as well as autoimmune diseases is rapidly growing across the globe. Stem cells and cell banks may have undesired burden of adventitious agents such as bacteria, viruses, protozoa among several others. Thus, these cell banks need to be free from adventitious agents to avoid proliferation of fatal infections. Thus, growing application of stem cells in regenerative medicine will thereby increase the demand for biological safety testing.

Pharmaceuticals & biopharmaceutical companies segment will foresee robust demand for biological safety testing in the foreseeable future. Increasing number of new market entrants offering novel therapeutics and drugs will escalate the requirement for safety testing. Additionally, established biopharmaceutical firms have several drugs in preclinical phase that will require safety testing from raw materials to final product manufacture, thus expanding the segmental growth potential over the estimation period.

Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/2337490/

Mergers and acquisitions, business expansion and product introductions are some of the chief strategies undertaken by the key industry players. In April 2015, Sartorius Stedim Biotech acquired contract biological testing service firm, BioOutsource Ltd. The acquisition was aimed in maintaining steady growth of organization and increase business portfolio across the U.S. and Asian countries.

Some major findings of the Biological Safety Testing market report include:

- The demand for biological safety testing is increasing owing to increase in number of drug discovery research activities for the treatment of broad range of serious disorders

- Increasing government initiatives and symposiums to encourage adoption of biologics safety testing to minimize contamination and optimize manufacturing procedure will boost the market growth

- Companies are introducing advanced biological safety testing solutions for recording safety data and research outcomes

- Major players operating biological safety testing market are Eurofins Scientific, Merck KGaA, Thermo Fisher Scientific, Esco, and Wuxi Biologics, among several others.

More Details on this Report At: https://www.marketstudyreport.com/reports/biological-safety-testing-market

About Us:

Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Info:
Name: Arun Hegde
Email: Send Email
Organization: Market Study Report LLC
Address: 4 North Main Street, Selbyville, Delaware 19975 USA
Phone: 1-302-273-0910
Website: https://www.marketstudyreport.com

Source URL: https://marketersmedia.com/biological-safety-testing-market-outlook-industry-growth-factors-applications-regional-analysis-key-players-and-forecasts-by-2025/88933499

Source: MarketersMedia

Release ID: 88933499

More News

Oct 4, 2026

Alex Eala takes act to Wuhan

Oct 4, 2026

La Salle downs UE in bounce-back win

DE La Salle University overwhelmed the University of the East, 70-55, to secure its first win in the UAAP Season 89 women’s basketball tournament on Sunday at the PhilSports Arena in Pasig City. After dropping their opening game against Far Eastern University last Wednesday, the Lady Archers improved to 1-1, while the Lady Warriors fell to 0-2 and suffered their 26th consecutive loss dating back to Season 87. “It’s a good character win for us that we came back from a loss, especially our first game. I’m not sure if it was the same team in the first game that I was coaching,” said DLSU head coach Cholo Villanueva. “It was just a far different team from that last game, and this is how we looked in the preseason. Because of the UAAP jitters, it’s a different environment so everybody is adjusting to the game, to the arenas, and the environment.” The Lady Archers came out firing, cruising to an 11-2 start before UE responded with a 5-0 run capped by Kristine Dalguntas’ triple to trim the deficit to six, 22-16, at the end of the opening frame. UE refused to let La Salle pull away in the second quarter, with Roshelle Lumibao’s midrange jumper giving the Lady Warriors their first lead of the game at 29-28. However, the momentum did not last long, as the Lady Archers answered with an 11-1 closing run to reclaim a 39-30 advantage at halftime. La Salle weathered every attempt from UE to claw its way back, maintaining a double-digit cushion throughout the third quarter before Bukky Ojo’s layup stretched the Lady Archers’ lead to 17, 55-38, heading into the final frame. DLSU continued to hound the Lady Warriors in the fourth quarter, limiting UE to just 15 points as the Lady Archers cruised to a 15-point victory. Kyla Go paced the Lady Archers with 18 points, three rebounds, and six steals, while 6-foot-3 Nigerian center Favour Ojo added 13 points, seven rebounds, and two assists. For UE, Rachel Lacayanga and Sy Onate led the team with 10 points apiece, while Lumibao chipped in seven points and three rebounds.

Oct 4, 2026

Alas men seek long-term system overhaul

Oct 4, 2026

Rybakina ousted by world No. 118 in China Open

BEIJING — World No.1 Elena Rybakina could not regroup and fell to 118th-ranked Alina Charaeva in the second round of the China Open on Saturday night in Beijing. The 27-year-old from Kazakhstan was playing her first match since seizing the top ranking on her US Open win in New York, but Armenia’s Charaeva triumphed, 3-6, 6-4, 6-3, in a clinical comeback. “I don’t have words,” said Charaeva, who is making her Beijing debut. “This is incredible,” the 24-year-old said. “She’s [an] amazing player, and for me it’s kind of just dream come true,” she said of Rybakina. “I will be really happy to stay some more days in Beijing,” she added. “Never stop believing, I guess.” Rybakina got off to a solid start, but seven double-faults ushered the momentum into the hands of her opponent. Wind rattled the closed-roof stadium, with both players serving as thunderous claps echoed over the court. A supportive crowd tried to rally Rybakina back into contention, but Charaeva held serve to win the match in two hours and 11 minutes. Charaeva faces Briton Sonay Kartal in the third round. Meanwhile, big-serving Alexander Zverev trounced home hopeful Shang Juncheng, 6-0, 6-3, to set up a quarterfinal clash with Novak Djokovic. The German top seed needed just 55 minutes to brush aside the Chinese wild card, ranked 250th, firing nine aces along the way. “Happy with the win,” the world’s second-ranked player said, adding that his 21-year-old opponent had been “dangerous” and had “nothing to lose.” “Looking forward to the next couple of weeks,” Zverev said ahead of his tie with Djokovic — who has never lost a match in Beijing — on Sunday. Zverev’s cruise into the next round comes as he trains his sights on the No. 1 spot currently held by Jannik Sinner. The Italian won in Beijing last year but is not there this time around. He said on Saturday that he would not play at next week’s Shanghai Masters either. “I think it’s no secret that it’s a goal, for sure,” Zverev told reporters when asked about the battle for No. 1. “I know what I’m playing for. I know I’m very, very motivated to play at the moment. But again, I have a tough challenge tomorrow, and that’s my focus,” he said. Also in the men’s draw, third seed Daniil Medvedev eased into the quarterfinals with a 6-4, 6-3 win over Germany’s Jan-Lennard Struff to play Argentina’s Francisco Cerundolo. Alex de Minaur, seeded fifth, and Andrey Rublev both needed three sets to advance and will play each other in the last eight. AFP

Oct 4, 2026

LeBron kicks off new era in Philadelphia

PHILADELPHIA — The 76ers' public address announcer ended a brief retirement over the summer in large part to get behind the mic and do what he did for the first time ahead of the team's annual scrimmage. Matt Cord introduced LeBron James in the Sixers' starting lineup. "At 6-9, from St. Vincent-St. Mary’s, No. 23, LeBron James! James!' Close to 10,000 fans who plunked down $10 a ticket on Saturday (Sunday in Manila) to essentially witness a glorified practice at the Sixers’ home arena went wild for James' debut. No, James didn't wear No. 23. He historically wore No. 6 over his career in practice gear but with that number retired in Philadelphia because of Julius Erving, James went with No. 9. No, the dunks and 3s and assists didn't count in any official capacity. And no, James wasn't even introduced last. That honor remained reserved for Joel Embiid. What the new 41-year-old on the block did do was give — along with Embiid, Tyrese Maxey, Jaylen Brown and VJ Edgecombe — a sneak preview that maybe, just maybe, the long underperforming Sixers might finally rise to the moment this season and meet their championship expectations. “It was a great first step in a direction we're trying to go,” James said. “It was great to hear some cheers from our fans.” Sixers fans that crammed aisles and stairways trying to catch a first glimpse or a snapshot of James were shooed back to their seats. Vendors hawked James merchandise outside the arena and told fans they could own the first pieces of his merchandise. Sixers fans that inched near the court screamed and outright begged James to stop and turnaround and pose for pictures. They also crammed into team stores buying No. 23 jerseys. The Sixers started the scrimmage early with what they hope is a familiar sight: Maxey in transition hit James for an alley-oop dunk. James hung and swung on the rim for a few seconds. James made a nifty behind-the-back pass to Edgecombe (who missed a corner 3) and even squared up and buried a long 3 from about Caitlin Clark range.